List of Excipients in API delgocitinib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing delgocitinib
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| LEO Pharma Inc | ANZUPGO | delgocitinib | 50222-280 | BENZYL ALCOHOL | 2030-07-23 |
| LEO Pharma Inc | ANZUPGO | delgocitinib | 50222-280 | BUTYLATED HYDROXYANISOLE | 2030-07-23 |
| LEO Pharma Inc | ANZUPGO | delgocitinib | 50222-280 | CETOSTEARYL ALCOHOL | 2030-07-23 |
| LEO Pharma Inc | ANZUPGO | delgocitinib | 50222-280 | CITRIC ACID MONOHYDRATE | 2030-07-23 |
| LEO Pharma Inc | ANZUPGO | delgocitinib | 50222-280 | EDETATE DISODIUM | 2030-07-23 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for delgocitinib
Excipient focus: BENZYL ALCOHOL
delgocitinib drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| LEO Pharma Inc | delgocitinib | 50222-280 |
| >Company | >Ingredient | >NDC |
delgocitinib drug variants not containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYANISOLE
delgocitinib drug variants containing BUTYLATED HYDROXYANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| LEO Pharma Inc | delgocitinib | 50222-280 |
| >Company | >Ingredient | >NDC |
delgocitinib drug variants not containing BUTYLATED HYDROXYANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CETOSTEARYL ALCOHOL
delgocitinib drug variants containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| LEO Pharma Inc | delgocitinib | 50222-280 |
| >Company | >Ingredient | >NDC |
delgocitinib drug variants not containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
delgocitinib drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| LEO Pharma Inc | delgocitinib | 50222-280 |
| >Company | >Ingredient | >NDC |
delgocitinib drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
delgocitinib drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| LEO Pharma Inc | delgocitinib | 50222-280 |
| >Company | >Ingredient | >NDC |
delgocitinib drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
delgocitinib drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| LEO Pharma Inc | delgocitinib | 50222-280 |
| >Company | >Ingredient | >NDC |
delgocitinib drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MINERAL OIL
delgocitinib drug variants containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| LEO Pharma Inc | delgocitinib | 50222-280 |
| >Company | >Ingredient | >NDC |
delgocitinib drug variants not containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 20 CETOSTEARYL ETHER
delgocitinib drug variants containing POLYOXYL 20 CETOSTEARYL ETHER
| Company | Ingredient | NDC |
|---|---|---|
| LEO Pharma Inc | delgocitinib | 50222-280 |
| >Company | >Ingredient | >NDC |
delgocitinib drug variants not containing POLYOXYL 20 CETOSTEARYL ETHER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
delgocitinib drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| LEO Pharma Inc | delgocitinib | 50222-280 |
| >Company | >Ingredient | >NDC |
delgocitinib drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
